Review of the risks and benefits of yellow fever vaccination including some new analyses

Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis

(2011) Mauricio F. Farez   ARCHIVES OF NEUROLOGY

Neurovirulence tests of three 17D yellow fever vaccine strains

(2011) Philip D. Minor   BIOLOGICALS

Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk

(2011) S. Kuhn et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

(2011) Garth L. Burn et al.   FEBS LETTERS

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

(2011) Emily S Jentes et al.   LANCET INFECTIOUS DISEASES

An Inactivated Cell-Culture Vaccine against Yellow Fever

(2011) Thomas P. Monath et al.   NEW ENGLAND JOURNAL OF MEDICINE

Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review

(2011) Roger E. Thomas et al.   VACCINE

Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model

(2011) Justin G. Julander et al.   VACCINE

Persistence of yellow fever vaccine RNA in urine

(2011) Miguel J. Martínez et al.   VACCINE

Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United States

(2010) Thomas P. Monath   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Immunogenicity and Tolerability of Yellow Fever Vaccination in 23 French HIV-Infected Patients

(2010) Thierry Pistone et al.   CURRENT HIV RESEARCH

Detection of Yellow Fever 17D Genome in Urine

(2010) C. Domingo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Variability in the 2′‐5′‐Oligoadenylate Synthetase Gene Cluster Is Associated with Human Predisposition to Tick‐Borne Encephalitis Virus–Induced Disease

(2010) Andrey V. Barkhash et al.   JOURNAL OF INFECTIOUS DISEASES

Knowledge, Attitudes, and Practices of Japanese Travelers on Infectious Disease Risks and Immunization Uptake

(2010) Kyoko Namikawa et al.   JOURNAL OF TRAVEL MEDICINE

Yellow fever vaccination coverage among children in Brazilian capitals

(2010) Maria Amélia S.M. Veras et al.   VACCINE

Is it time for a new yellow fever vaccine?

(2010) Edward B. Hayes   VACCINE

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009

(2010) Morag Ferguson et al.   VACCINE

Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

(2010) Thomas P. Monath et al.   VACCINE

Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults

(2010) Maria Luiza Silva et al.   VACCINE

The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells

(2010) H. Elbahesh et al.   VIROLOGY

The Need for Organization and Collaboration: Establishing a Thymoma Registry

(2010) Pascal A. Thomas   Thoracic Surgery Clinics

Incidence of Yellow Fever Vaccine-Associated Neurotropic Disease

(2009) Thomas Guimard et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Population-based lupus registries: Advancing our epidemiologic understanding

(2009) S. Sam Lim et al.   ARTHRITIS AND RHEUMATISM

Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients

(2009) Olivia Veit et al.   CLINICAL INFECTIOUS DISEASES

Yellow fever vaccine—how does it work and why do rare cases of serious adverse events take place?

(2009) Alan DT Barrett et al.   CURRENT OPINION IN IMMUNOLOGY

Safety of 17D derived yellow fever vaccines

(2009) Cristina Domingo et al.   Expert Opinion On Drug Safety

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies

(2009) Lesley A. Anderson et al.   INTERNATIONAL JOURNAL OF CANCER

Persistent Infection with West Nile Virus Years after Initial Infection

(2009) Kristy Murray et al.   JOURNAL OF INFECTIOUS DISEASES

Yellow Fever in a Brazilian Family Returning From Vacation in an Endemic Area: Relevant Clinical Features and Epidemiological Issues: Table 1

(2009) Tânia S. S. Chaves et al.   JOURNAL OF TRAVEL MEDICINE

Yellow Fever Vaccination and Kawasaki Disease

(2009) Deonilson Schmöeller et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Vaccination as a Triggering Event for Autoimmune Hepatitis

(2009) Ponni Perumalswami et al.   SEMINARS IN LIVER DISEASE

Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy

(2009) Anna H. Roukens et al.   VACCINE

Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system

(2009) Anna P. Durbin et al.   VACCINE

Viscerotropic disease following yellow fever vaccination in Peru

(2009) Alvaro Whittembury et al.   VACCINE

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

(2009) Kathryn C. Meier et al.   PLoS Pathogens

Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man

(2009) Jean K. Lim et al.   PLoS Pathogens

Yellow fever vaccines and international travelers

(2008) Elizabeth D Barnett et al.   Expert Review of Vaccines

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

(2008) Denis Gaucher et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters

(2008) X. Wu et al.   JOURNAL OF GENERAL VIROLOGY

Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in Europe

(2008) Hi‐Gung Bae et al.   JOURNAL OF INFECTIOUS DISEASES

Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes

(2008) Bali Pulendran et al.   JOURNAL OF INFECTIOUS DISEASES

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

(2008) Troy D Querec et al.   NATURE IMMUNOLOGY

Adverse event reports following yellow fever vaccination

(2008) Nicole P. Lindsey et al.   VACCINE

Treatment of yellow fever

(2007) Thomas P. Monath   ANTIVIRAL RESEARCH